FOI.ICB-2526/217: Commissioning and Activity Data for GLP-1 Weight-loss Medicines FOI.ICB-2526/217: Commissioning and Activity Data for GLP-1 Weight-loss Medicines Nazwa pliku: FOI.ICB-2526_217-WEIGHT-LOSS-MEDICINES-AND-TIER-3-SERVICES-FINAL-RESPONSE.PDF Typ pliku: PDF Rozmiar pliku: 266 KB Pobierz